CMS Proposal Would Cut Payment for Same-Day Injection Visits

• by Jim Gallagher, senior managing editor

• July 15, 2026

Efficacy of intradermal acupuncture for ocular surface diseases secondary to refractory peripheral facial palsy: a randomized controlled trial study protocol

• by Jiayi Yao, Lusha Cen, Qiushuang Li, Shan Liu, Chenjia Zhu, Lihua Xuan, Binyan Yu

• July 20, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

• by Andrea Surnit

• July 20, 2026

• 3 min

OLN324: Why Size May Matter

David A. Eichenbaum, MD, FASRS, and Veeral S. Sheth, MD, MBA, discuss phase 1 JADE findings and how OLN324's small-format design may contribute to improved retinal drying in nAMD and diabetic macular edema.

• by David A. Eichenbaum, MD, Veeral S. Sheth, MD, MBA, FACS

• July 15, 2026

• 3 min